Monthly Archives: July 2012

'Porky' hid drugs in cemeteries

Posted: Published on July 30th, 2012

An alleged boss of the Wellington Nomads hid a stash of thousands of dollars worth of methamphetamine in cemeteries, a court has been told. Paul Peter Mawana Rodgers, known as Porky Rimene, has pleaded guilty to supplying meth between July 2009 and February 2011, offering to supply the drug, conspiring to obstruct the course of justice, money laundering and taking part in a criminal group. He is accused of distributing more than three kilograms of meth - with a street value of $3 million - into the Wellington region. An unnamed witness told the High Court at Wellington on Monday that Rodgers had so many places to bury drugs and money that it was hard to keep track of them, Fairfax reported. The witness said he buried drugs and money at sites around Wellington and Wairarapa, including at a private urupa or cemetery in Masterton. A groundsman at Riverside Cemetery in Masterton also found a container of about $7000 worth of meth. At one stage a bulldozer working on a public track displaced a buried container and they had to use a hired metal detector to find it. The witness said Rodgers told him he would be buried if he … Continue reading →

Posted in Drugs | Comments Off on 'Porky' hid drugs in cemeteries

DRX Expands Coverage of Specialty Drugs

Posted: Published on July 30th, 2012

LOS ANGELES--(BUSINESS WIRE)-- DRX, a leading provider of healthcare comparison tools, technology and data, announced today that the company is expanding its coverage of specialty drugs in its popular DrugCompare technology. DRX DrugCompare is the leading platform for identifying lower cost drug alternatives for prescription drugs. This technology provides the most comprehensive set of therapeutically equivalent drug mappings available, offering dose-specific price comparisons for branded, generic and therapeutic equivalents of prescription drugs. The Lower-Cost Alternatives data in DrugCompare is the most widely-used comparative effectiveness solution in the US. It is used by health plans, pharmacy benefit managers (PBMs), drugstore chains, online pharmacies, consulting firms, electronic medical records providers (EMRs) and e-Prescribing vendors. In the area of Specialty medications, DRX currently covers therapeutic alternatives for Anemia, Hepatitis C, and Multiple Sclerosis. The Specialty drug spend continues to be a major factor in our clients overall drug spend, so DRX is working hard to continue to expand our coverage in this area. By the end of 2012, we plan to add at least 4 more Specialty medications to our suite. These include medications for Pulmonary Arterial Hypertension, said Toby Rogers, COO of DRX. In 2013, we will focus on enhancing our alternatives … Continue reading →

Posted in Drugs | Comments Off on DRX Expands Coverage of Specialty Drugs

Anesthesia Drugs Market (2011 – 2015) – U.S. Market Entry Study

Posted: Published on July 30th, 2012

NEW YORK, July 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study http://www.reportlinker.com/p0864779/Anesthesia-Drugs-Market-2011---2015---US-Market-Entry-Study.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and general anesthetic drugs. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation. The anesthesia drugs market research report specially focuses on ketamine market in U.S.A. Under general anesthesia drugs category, drugs such as propofol, midazolam & diazepam, fospropofol disodium, sodium pentothal, ketamine, methohexital sodium, pentobarbital, etomidate and fentanyl are studied. The U.S. general anesthesia market was valued at $2 billion in 2011 and is poised to grow at a CAGR of approximately 4% to reach $2.3 billion by 2015. Advantages offered by general anesthesia includes - rapid onset of anesthesia, full control of the body processes (airway, respiratory and circulatory system), used in surgeries with unpredictable duration … Continue reading →

Posted in Drugs | Comments Off on Anesthesia Drugs Market (2011 – 2015) – U.S. Market Entry Study

Drugs are everywhere and 'glorified' say grieving parents

Posted: Published on July 30th, 2012

"It's too easy for teenagers to get hold of drugs. Drugs are everywhere and somebody will always know somebody who will sell you some. "Unfortunately there are websites where people talk openly about their drug habits and which drugs they like and don't like and glorify the effects." Explaining their daughter rarely drank or went to parties due to suffering Crohns disease, Mrs Harding, who provides holistic care for drug addicts, and her husband said: Serena just wanted to be like everybody else her age. We believe Serena got out of her depth and gave in to peer pressure. Every day we ask ourselves `how can this be?' Serena filled all our hearts; she was so loving and caring and was sometimes wise beyond her almost 17 years. "The tears we cry everyday are futile because she will never come home again. Miss Harding, who was studying a fashion and design course in Warrington, Cheshire, took the drug with friends while celebrating her exam results on August 21. Manchester Crown Court heard she had been encouraged to take it by Michael Millington, 19, who Serena knew well and had a crush on. A friend later said she had wanted to … Continue reading →

Posted in Drugs | Comments Off on Drugs are everywhere and 'glorified' say grieving parents

Propecia Online Pharmacy Uk

Posted: Published on July 30th, 2012

Por FRANK GAUD CARRAU MAYAGEZ (AP) El representante por el distrito de Mayagez y San Germn, que en enero empez su tercer cuatrienio en la Cmara Baja, dijo que comenzar a evaluar su futuro poltico, en el que no descarta del todo aspirar a otro puesto electivo. "Ser el tiempo el que se encargar de definir mi futuro poltico o profesional, pero seguir confrontando a quienes deseen llevar a mi partido y a Puerto Rico por caminos de inmovilismo y sumisin", manifest el legislador en conferencia de prensa al recordar que haba prometido que no optara por ms de tres trminos a una misma posicin. Aunque dej la puerta abierta a aspirar a otro cargo electivo, Hernndez rechaz rotundamente que interese ocupar la alcalda mayagezana. Asimismo, afirm que continuar luchando por que el PPD "se mueva a mejorar un ELA soberano". Durante los pasados meses, Hernndez y otras figuras populares han confrontado al liderato del PPD y a la Comisin de Asuntos Federales de esa colectividad creada para discutir el asunto del estatus por las marcadas diferencias entre ambos respecto a la direccin que debe tomar el partido en torno a la definicin poltica de Puerto Rico. El debate se … Continue reading →

Posted in Online Pharmacy | Comments Off on Propecia Online Pharmacy Uk

O.C. health firm sells pharmacy division

Posted: Published on July 30th, 2012

O.C. health firm sells pharmacy division July 30th, 2012, 9:30 am posted by Jan Norman, small-business columnist A-Med Health Care in Huntington Beach has sold its specialty pharmacy division to Altamont Capital Partners, a Palo Alto private equity firm. Altamont is creating a new company, called ModernHEALTH Specialty Pharmacy, which will combine A-Meds assets and the specialty pharmacy operations of Modern HEALTHcare Inc. in Monrovia. Terms of the deals were not disclosed. In a letter to customers, A-Med Health Care CEO Larry Thacker said, Going forward, A-Med will continue to service its medical supply and enteral nutrition patients and health care providers, as well as maintain its industry leading position as the premier medical supply provider in California. The new ModernHEALTH Specialty will be based in Monrovia and serve the needs of patients in 15 states. The company will focus on specialty infusion, particularly IVIG therapy, as well as specialty pharmaceutical therapies with high service needs such as HIV, cystic fibrosis, transplants, hepatitis C and multiple sclerosis. Richard Katz, CEO of ModernHEALTH Specialty Pharmacy, Over the years we have built a substantial specialty pharmacy business at Modern including BioFusion, a leader in the specialty infusion market. Continuing to build these … Continue reading →

Posted in Pharmacy | Comments Off on O.C. health firm sells pharmacy division

CVS/pharmacy's "Project Health" Bringing Free Health Screenings to 10 Cities During August

Posted: Published on July 30th, 2012

WOONSOCKET, R.I., July 30, 2012 /PRNewswire/ -- Throughout the month of August, which is National Immunization Awareness Month, CVS/pharmacy's Project Health ("Proyecto Salud" in Spanish) is offering free health screening events focusing on vaccination reviews, vision acuity, glucose, blood pressure and BMI (Body Mass Index) for individuals in multicultural communities who have difficulty accessing preventive care. (Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO ) (Logo: http://photos.prnewswire.com/prnh/20120207/NE48106LOGO-a ) Along with these free health screening events, CVS/pharmacy designated Project Health store locations are also holding "Flu Voucher Fridays" each week during the month of August. Qualifying Project Health attendees who complete the entire health screening process and identify themselves as not having health insurance will be eligible to receive a voucher redeemable for a flu shot at CVS/pharmacy or MinuteClinic this flu season. More than 200 Project Health events will take place during the month of August in the following cities: Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York City, Philadelphia and Washington, D.C. Parents are encouraged to bring their children's immunization records to the events in preparation for school. Although children age seven and older can participate in only two screenings vaccination reviews and vision acuity they are eligible to qualify to receive … Continue reading →

Posted in Pharmacy | Comments Off on CVS/pharmacy's "Project Health" Bringing Free Health Screenings to 10 Cities During August

CVS/pharmacy and MinuteClinic Launch Flu Shot Voucher Program for Patients in Need This Flu Season

Posted: Published on July 30th, 2012

WOONSOCKET, R.I., July 30, 2012 /PRNewswire/ -- CVS/pharmacy and MinuteClinic will support people in need this flu season through a flu shot voucher program being held in August as part of CVS/pharmacy's Project Health free screening events. Qualifying patients who attend a "Flu Voucher Fridays" Project Health event, complete the screenings, and identify themselves as not having health insurance will receive a voucher redeemable for a flu shot at any CVS/pharmacy or MinuteClinic location this flu season. (Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO ) The flu shot vouchers are being offered as part of National Immunization Awareness Month. CVS/pharmacy's Project Health (Proyecto Salud in Spanish) is also offering free health screening events in August. Screenings will focus on vaccination reviews, vision acuity, glucose, blood pressure and Body Mass Index (BMI) for individuals in multicultural communities who have difficulty accessing preventive care. More than 200 Project Health events will take place in Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York City, Philadelphia and Washington, DC. "CVS/pharmacy and MinuteClinic are committed to being the most convenient place to get a flu shot this season," said Papatya Tankut, Vice President, Pharmacy Professional Services at CVS/pharmacy. "Offering flu shot vouchers to patients who may have … Continue reading →

Posted in Pharmacy | Comments Off on CVS/pharmacy and MinuteClinic Launch Flu Shot Voucher Program for Patients in Need This Flu Season

CoramRx Specialty Pharmacy Services Receives URAC Specialty Pharmacy Accreditation

Posted: Published on July 30th, 2012

DENVER, July 30, 2012 (GLOBE NEWSWIRE) -- CoramRx Specialty Pharmacy Services announced today that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC's Specialty Pharmacy Accreditation ensures that organizations meeting the rigors of accreditation uphold the highest standards in the industry, and reinforces the best clinical and organizational practices for ensuring appropriate and safe medication use and optimal patient outcomes. "The growth of CoramRx's customer base in the managed care and prescription benefit manager community led to the need to seek a second accreditation for the business," said Lori Jordon, Director of Operations for CoramRx. "What makes URAC unique is its focus on and standardization of the quality improvement process and ongoing reporting of performance metrics for organizations seeking accreditation." CoramRx offers national distribution and local services through specialty pharmacy facilities, more than 85 infusion pharmacies, and over 65 ambulatory infusion suites across the United States. With more than 30 years of industry experience, clinical knowledge, and dedicated pharmacy teams, it ensures optimal access to all types of specialty products including oral, injectable, and infusible medications. CoramRx is an affiliate of Coram Specialty … Continue reading →

Posted in Pharmacy | Comments Off on CoramRx Specialty Pharmacy Services Receives URAC Specialty Pharmacy Accreditation

Osiris Therapeutics falls as Sanofi tiff continues

Posted: Published on July 30th, 2012

NEW YORK (AP) -- Shares of Osiris Therapeutics Inc. fell Monday as the company said it is still negotiating with French drugmaker Sanofi about the rights to its stem cell therapy Prochymal. Osiris President and CEO Randal Mills said his company's dispute with Sanofi is "in the hands of lawyers" and that Osiris and Sanofi are trying to amicably resolve their disagreements over the status of Prochymal. The therapy is a treatment for graft vs. host disease, a condition in which transplanted bone marrow cells attack the body of the patient. The Columbia, Md., company was developing Prochymal through a partnership with biotechnology company Genzyme. French drugmaker Sanofi later acquired Genzyme, and in February, Sanofi said it discontinued late-stage testing of Prochymal. Osiris said that means the collaboration is over and it should regain the rights to Prochymal, allowing it to market the drug or find another partner. Sanofi disagrees. Shares of Osiris Therapeutics fell 95 cents, or 9.5 percent, to $9.08 in afternoon trading. Canadian regulators granted conditional approval to Prochymal in May, and regulators in New Zealand gave full approval to Prochymal in June. In a conference call, Osiris said it expects Prochymal to be available in Canada … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Osiris Therapeutics falls as Sanofi tiff continues